Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Immunomodulating and antiviral activities of the imidazoquinoline S-28463.

Tomai MA, Gibson SJ, Imbertson LM, Miller RL, Myhre PE, Reiter MJ, Wagner TL, Tamulinas CB, Beaurline JM, Gerster JF, et al.

Antiviral Res. 1995 Nov;28(3):253-64.

PMID:
8629817
2.

Effect of a novel topical immunomodulator, S-28463, on keratinocyte cytokine gene expression and production.

Fujisawa H, Shivji GM, Kondo S, Wang B, Tomai MA, Miller RL, Sauder DN.

J Interferon Cytokine Res. 1996 Jul;16(7):555-9.

PMID:
8836922
3.

Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463.

Wagner TL, Horton VL, Carlson GL, Myhre PE, Gibson SJ, Imbertson LM, Tomai MA.

Cytokine. 1997 Nov;9(11):837-45.

PMID:
9367544
4.

Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod.

Miller RL, Imbertson LM, Reiter MJ, Gerster JF.

Antiviral Res. 1999 Nov;44(1):31-42.

PMID:
10588331
5.
6.

Imiquimod applied topically: a novel immune response modifier and new class of drug.

Miller RL, Gerster JF, Owens ML, Slade HB, Tomai MA.

Int J Immunopharmacol. 1999 Jan;21(1):1-14. Review.

PMID:
10411278
7.

Immunomodulatory and pharmacologic properties of imiquimod.

Sauder DN.

J Am Acad Dermatol. 2000 Jul;43(1 Pt 2):S6-11. Review.

PMID:
10861101
8.

Synthesis and structure-activity-relationships of 1H-imidazo[4,5-c]quinolines that induce interferon production.

Gerster JF, Lindstrom KJ, Miller RL, Tomai MA, Birmachu W, Bomersine SN, Gibson SJ, Imbertson LM, Jacobson JR, Knafla RT, Maye PV, Nikolaides N, Oneyemi FY, Parkhurst GJ, Pecore SE, Reiter MJ, Scribner LS, Testerman TL, Thompson NJ, Wagner TL, Weeks CE, Andre JD, Lagain D, Bastard Y, Lupu M.

J Med Chem. 2005 May 19;48(10):3481-91.

PMID:
15887957
9.

Cytokine induction in mice by the immunomodulator imiquimod.

Reiter MJ, Testerman TL, Miller RL, Weeks CE, Tomai MA.

J Leukoc Biol. 1994 Feb;55(2):234-40.

PMID:
7507969
10.
11.

Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs.

Harrison CJ, Stanberry LR, Bernstein DI.

Antiviral Res. 1991 May;15(4):315-22.

PMID:
1659313
12.

Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609.

Gibson SJ, Imbertson LM, Wagner TL, Testerman TL, Reiter MJ, Miller RL, Tomai MA.

J Interferon Cytokine Res. 1995 Jun;15(6):537-45.

PMID:
7553223
13.

Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463.

Imbertson LM, Beaurline JM, Couture AM, Gibson SJ, Smith RM, Miller RL, Reiter MJ, Wagner TL, Tomai MA.

J Invest Dermatol. 1998 May;110(5):734-9.

14.

Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.

Kawamoto S, Oritani K, Asada H, Takahashi I, Ishikawa J, Yoshida H, Yamada M, Ishida N, Ujiie H, Masaie H, Tomiyama Y, Matsuzawa Y.

J Virol. 2003 Sep;77(17):9622-31.

15.
16.

VIP induces in HT-29 cells 2'5'oligoadenylate synthetase and antiviral state via interferon beta/alpha synthesis.

Chelbi-Alix MK, Boissard C, Sripati CE, Rosselin G, Thang MN.

Peptides. 1991 Sep-Oct;12(5):1085-93.

PMID:
1724797
17.
18.

2',5'-oligoadenylate synthetase in interferon-alpha- and acyclovir-treated herpes simplex virus-infected cells.

Taylor JL, Witt PL, Irizarry A, Tom P, O'Brien WJ.

J Interferon Cytokine Res. 1995 Jan;15(1):27-30.

PMID:
7648430
19.

Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase.

Mestan J, Brockhaus M, Kirchner H, Jacobsen H.

J Gen Virol. 1988 Dec;69 ( Pt 12):3113-20.

PMID:
2462015
20.

Supplemental Content

Support Center